Deals
Tokai Pharma Signs US$35.5M in Series E
Tokai Pharma receives US$35.5 series E capital financing round. Tokai Pharmaceuticals, Inc announced today that it was able to secure US$35. 5 million in a round of Series E growth financing in order to persuade investors to support Tokai's lead prostate cancer pharmaceutical product currently in medical development.
Bayside Capital Invests in Consolis
Bayside Capital and LBO France invest in Consolis. In an announcement today by Bayside Capital, it disclosed that a venture fund administered by Bayside had concluded a venture in Consolis, a renowned European producer of assembled concrete products.
Larsen and Toubro to Sell Inflation Linked Bonds
Larsen and Toubro, following the lead of the Singh government, is selling inflation pegged bonds to the market.
Zoove Corp Secured US$15 Million from Current Investors
Zoove Corp secures another US$15 million from current investor pool. Zoove Corporation disclosed in an announcement that it was able to get a calculated investment of US$15 million from its current Series D investors Panorama Capital and Rogers Venture Partners.